Kay Tetzlaff

Kay Tetzlaff

Universität Tubingen - Tübingen / Germany
Medical and Health Sciences / Immunology
AD Scientific Index ID: 1787658
Eberhard Karls University of Tübingen
person_outline Kay Tetzlaff's MOST POPULAR ARTICLES
1-) Nintedanib in progressive fibrosing interstitial lung diseasesKR Flaherty, AU Wells, V Cottin, A Devaraj, SLF Walsh, Y Inoue, ...New England Journal of Medicine 381 (18), 1718-1727, 201910472019
2-) Nintedanib for systemic sclerosis–associated interstitial lung diseaseO Distler, KB Highland, M Gahlemann, A Azuma, A Fischer, MD Mayes, ...New England Journal of Medicine 380 (26), 2518-2528, 20198922019
3-) Withdrawal of inhaled glucocorticoids and exacerbations of COPDH Magnussen, B Disse, R Rodriguez-Roisin, A Kirsten, H Watz, K Tetzlaff, ...N Engl J Med 371, 1285-1294, 20147242014
4-) Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trialH Watz, K Tetzlaff, EFM Wouters, A Kirsten, H Magnussen, ...The lancet Respiratory medicine 4 (5), 390-398, 20165282016
5-) Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4)R Buhl, F Maltais, R Abrahams, L Bjermer, E Derom, G Ferguson, ...European Respiratory Journal 45 (4), 969-979, 20154472015